Proteomics International Laboratories (ASX:PIQ) Accounts Payable & Accrued Expense : A$0.79 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Accounts Payable & Accrued Expense?

Proteomics International Laboratories's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$0.36 Mil) to Jun. 2023 (A$0.58 Mil) and increased from Jun. 2023 (A$0.58 Mil) to Dec. 2023 (A$0.79 Mil).

Proteomics International Laboratories's annual accounts payable & accrued expense increased from Jun. 2021 (A$0.26 Mil) to Jun. 2022 (A$1.15 Mil) but then declined from Jun. 2022 (A$1.15 Mil) to Jun. 2023 (A$0.58 Mil).

Proteomics International Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for Proteomics International Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Accounts Payable & Accrued Expense Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.30

0.45

0.26

1.15

0.58

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial													0.41	1.15	0.36	0.58	0.79

Proteomics International Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Proteomics International Laboratories (ASX:PIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines